News and Press Releases
Symeres and Ambagon Therapeutics collaborate on molecular glue research in colorectal cancer
31 March 2026 -- Nijmegen, Netherlands -- Symeres, a leading CRDMO for drug discovery and development has partnered with Ambagon Therapeutics, a pre-clinical biotechnology company, to explore a new class...
Category: Biotechnology, Drug Discovery, Other, Pharmaceutical
Posted: March 31, 2026
Vandria Reports Positive Phase 1 Target Engagement Data for VNA-318, Supporting Further Development in Alzheimer’s Disease
Results presented at the 18th Clinical Trials in Alzheimer's Disease (CTAD) meeting, San Diego, December 1-4 VNA-318, an oral brain-penetrant small molecule therapeutic modulates a novel target to reduce inflammation...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: December 2, 2025
Redx presents Phase 1 data supporting RXC008 as a novel and well tolerated drug candidate in development for the potential treatment of fibrostenotic Crohn’s disease
Orally administered pan-ROCK inhibitor demonstrated intestinal tissue exposure and target engagement with minimal plasma concentrations A Phase 2 study is being planned. 6 May 2025 -- Alderley Park, UK --...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: May 6, 2025
Block 33 Mereside, Alderley Park Alderley Edge Macclesfield SK10 4TG UK
Pharming receives positive recommendation from NICE for Joenja▼(leniolisib) as a treatment for APDS
Joenja® is the first and only medicine specifically for APDS to be reimbursed within the NHS Recommended for adult and pediatric patients 12 years of age and older with activated...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 23, 2025
Pharming Group N.V. Vondellaan 47 2332 AA Leiden The Netherlands
Accure Therapeutics awarded total of $1.6M in grants from The Michael J. Fox Foundation and Fonds National de Recherche de Luxembourg to bring first-in-class drug for Parkinson’s disease to clinical trials
Accure to complete required preclinical studies to file IND application for ACT-02 program in 2026 Fonds National de Recherche (FNR) grant will fund Transcend-PD project, designed to evaluate efficacy of...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: April 7, 2025
Advarra Introduces Comprehensive Solution to Accelerate Study Startup and Improve Collaboration on Trials
Proven technology powers end-to-end solution designed to streamline site activation workflows, improve engagement, and optimize visibility among trial stakeholders 21 January 2025 -- Maryland, US -- Advarra, the market leader...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: January 21, 2025
Signant Health and SPRIM PRO Align to Advance eClinical Solutions for Specialized Clinical Research
30 October 2024 -- Pennsylvania, US -- Signant Health, the leader in evidence generation for modern clinical trials, today announced a strategic alignment with SPRIM PRO, a boutique contract research...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: October 30, 2024
Coronado Research Limited announce appointment of Professor Jennifer Visser-Rogers as Chief Scientific Officer
24 October 2024 -- London, UK -- Coronado Research announced today that Professor Jennifer Visser-Rogers has been appointed as Chief Scientific Officer. Jennifer brings with her a broad portfolio of...
Category: Biotechnology, Clinical Trials, Drug Discovery
Posted: October 24, 2024
CPHI Milan analysis ‘Lombardy the best location for pharma manufacturing in Europe’
Report predicts significant growth for Lombardy’s pharma industry in 2025 as event directly contributes more than €120m to region 3 October 2024 – Milan, Italy – The global pharma industry...
Category: Pharmaceutical
Posted: October 3, 2024
Tracey Marantal Joins Worldwide Clinical Trials as President, Oncology Business Unit
Proven clinical operations leader joins global CRO to lead high-performing therapeutic team and drive strategy for growing oncology portfolio 24 September 2024 -- North Carolina, US -- Tracey Marantal has...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 24, 2024
600 Park Offices Drive Suite 200 Research Triangle Park, NC 27709 USA
PlaqueTec and RxCelerate collaborate on early phase drug discovery for coronary artery disease
Project evaluated small molecules against novel target in coronary artery disease discovered by PlaqueTec Bespoke cell-based assay developed by RxCelerate to test small molecules predicted to bind candidate target. 18...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: September 18, 2024
CPHI Annual Report 2024: CPHI Milan Report predicts BLA and Tides approvals will surpass small molecules within the next three years
Bio and Tides predicted to be the fastest growing modality for CDMOs over the next five years 12 September 2024 – Milan, Italy – Ahead of CPHI Milan – the...
Category: Pharmaceutical
Posted: September 12, 2024
Thermo Fisher Scientific’s Clinical Research Business Recognized by ISG for Digital Services Leadership
The PPD clinical research business has been named a leader in digital solutions and services by ISG for four consecutive years 14 August 2024 -- North Carolina, US -- The...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: August 15, 2024
Mission Therapeutics awarded $5.2m from The Michael J Fox Foundation and Parkinson’s UK to advance potential disease-modifying treatment MTX325
Investment will support investigation of Mission’s small molecule drug MTX325 in patients with early-stage Parkinson’s disease Marks latest step in Mission’s relationship with The Michael J Fox Foundation (MJFF), after...
Category: Biotechnology, Clinical Trials, Drug Discovery, Pharmaceutical
Posted: July 2, 2024
Moneta (Building 280), Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
Thermo Fisher Scientific Expands Clinical Research Laboratory in Kentucky
The PPD clinical research business will nearly double its laboratory footprint in northern Kentucky, add more than 250 jobs 27 June 2024 -- North Carolina, US -- The PPD clinical...
Category: Biotechnology, Clinical Trials, Pharmaceutical
Posted: June 27, 2024
